Romero-Matas M, Pantoja-Garrido M, Frías-Sánchez Z, Jiménez-Gallardo J, del Valle Aguilar-Martín M, Gutiérrez-Domingo Á

Language: Spanish
References: 11
Page: 187-193
PDF size: 256.46 Kb.

ABSTRACT

Background: There are multiple approaches to perform a hysterectomy; the classic vaginal route, the laparotomic abdominal or the newest endoscopic techniques, such as laparoscopic or robotic. In patients undergoing benign pathology, the technique can only be performed by removing the uterine body (subtotal or supracervical hysterectomy). However, the concern about the possible occurrence of a neoplastic lesion in the remaining cervical stump has led to investigations into the benefits of also performing the cervical exeresis (total hysterectomy). Our goal is to present a review on the current situation of the topic, concluding that there is still no scientific consensus on which technique is the most recommended.
Clinical case: 36-year-old woman who underwent supracervical hysterectomy with laparoscopic bilateral salpinguectomy due to symptomatic myomatous uterus. After surgery, he presented a high-grade preneoplastic lesion, which indicated that cervical conization was indicated.
Conclusion: Some experts argue that the risks of performing the removal of the cervix are notable enough to indicate subtotal technique in patients without a history of disfunciocervical pathology, especially if they have adhesion or endometriosis of the rectovaginal septum. On the contrary, other working groups indicate that cervical preservation is not justified due to the low complication rate of the total hysterectomy technique and the possibility of developing a subsequent neoplastic pathology.

REFERENCES

1. Papadopoulos MS, et al. Hysterectomy: Current Methods and Alternatives for Benign Indications. Obstet. Gynecol Int 2010; 2010. https://doi.org/10.1155/2010/356740.

2. Lethaby A, et al. Total versus subtotal hysterectomy for benign gynaecological conditions (Review). Cochrane Database Syst Rev. 2012 Apr 18; (4): CD004993. https:// doi.org/10.1002/14651858.CD004993.pub3.

3. Ford JF, Feinstein SM. Human Papillomavirus Testing Before Elective Supracervical Hysterectomy. J Low Genit Tract Dis 2005; 9 (4): 230-1. doi: 10.1097/01. lgt.0000179863.52327.87.

4. Pouwels NS, et al. Cervix removal at the time of hysterectomy: factors affecting patients’ choice and effect on subsequent sexual function. Eur J Obstet Gynecol Reprod Biol. 2015; 195: 67-71. https://doi.org/10.1016/j.ejogrb. 2015.09.040.

5. Okaro EO, et al. Long-term outcome following laparoscopic supracervical hysterectomy. BJOG 2001; 108 (10): 1017-20. https://doi.org/10.1016/S0306-5456(01)00252-2.

6. Bojahr B, et al. Laparoscopic Supracervical Hysterectomy: a Retrospective Analysis of 1000 Cases. JSLS 2009; 13 (2):129-34.

7. Iftikhar R. The outcome of subtotal abdominal hysterectomy. J Coll Physicians Surg Pak. 2005; 15 (10): 594-6.

8. Farley JH, Taylor RR. Cervical Carcinosarcoma Occurring after Subtotal Hysterectomy, a Case Report. Gynecol Oncol 1997; 67 (3): 322-4.

9. Stumbar SE, et al. Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management. Prim Care 2019; 46 (1): 117-34. doi: 10.1016/j.pop.2018.10.011. https://doi.org/10.1016/j. pop.2018.10.011.

10. Castle PE, Pierz A. Once in Her Lifetime: Global Cervical Cancer Prevention. Obstet Gynecol Clin North Am 2019; 46 (1): 107-23. doi: 10.1016/j.ogc.2018.09.007. https:// doi.org/10.1016/j.ogc.2018.09.007.

11. Egli-Gany D, et al. Human papillomavirus genotype distribution and socio-behavioral characteristics in women with cervical precancer and cancer at the start of a human papillomavirus vaccination program: the CIN3+ plus study. BMC Cancer 2019; 19 (1): 111. doi: 10.1186/s12885-018-5248-y.